Protein Expression Market Size Is Set To Grow By USD 3.40 Billion From 2024-2028, Increasing Advances In Proteomics Research Boost The Market, Technavio


(MENAFN- PR Newswire) NEW YORK, June 28, 2024 /PRNewswire/ -- The global
protein expression market
size is estimated to grow by USD 3.40
billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost
16.1%
during the forecast period. Increasing advances in proteomics research
is driving market growth,
with a trend towards
increasing importance of promotional activities. However,
lack of skilled laboratory professionals
poses a challenge. Key market players include Agilent Technologies Inc., Amgen Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bioneer Corp., Danaher Corp., GenScript Biotech Corp., LGC Science Group Holdings Ltd., Lonza Group Ltd., Merck and Co. Inc., New England Biolabs Inc., Oxford Expression Technology Ltd., Pfizer Inc., Promega Corp., QIAGEN NV, Sartorius AG, Sino Biological Inc., Synbio Technologies, Takara Holdings Inc., and Thermo Fisher Scientific Inc..

Continue Reading

Protein Expression Market Size Is Set To Grow By USD 3.40 Billion From 2024-2028, Increasing Advances In Proteomics Research Boost The Market, Technavio Image

Technavio has announced its latest market research report titled Global protein expression market 2024-2028

Get a detailed analysis on regions, market segments, customer landscape, and companies-
View the snapshot of this report

Protein Expression Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 - 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 16.1%

Market growth 2024-2028

USD 3400.7 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

13.51

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key countries

US, UK, China, Germany, and Japan

Key companies profiled

Agilent Technologies Inc., Amgen Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bioneer Corp., Danaher Corp., GenScript Biotech Corp., LGC Science Group Holdings Ltd., Lonza Group Ltd., Merck and Co. Inc., New England Biolabs Inc., Oxford Expression Technology Ltd., Pfizer Inc., Promega Corp., QIAGEN NV, Sartorius AG, Sino Biological Inc., Synbio Technologies, Takara Holdings Inc., and Thermo Fisher Scientific Inc.

Market Driver

The Protein Expression Market faces unique challenges due to niche applications and regulatory restrictions. Brand visibility plays a minimal role in sales. Instead, vendors focus on expanding distribution networks and increasing product availability to end-users. Marketing and advertising are restricted, leading to low awareness. Thermo Fisher Scientific and Bio-Rad Laboratories use YouTube to educate customers about protein expression products. Non-profit research organizations collaborate with pharmaceutical companies to promote awareness. Product enhancements necessitate promotional activities, which is a growing trend in the market.

The Protein Expression market is experiencing significant growth due to the increasing demand for advanced therapeutics and research applications. Recombinant proteins are in high demand, particularly in the biotechnology industry. The use of prokaryotic and eukaryotic systems for protein expression is a trending topic. Cells and organisms such as E. Coli, yeast, and mammalian cells are commonly used for protein production. The Cryopreservation of these cells is crucial for maintaining their viability and ensuring consistent protein yields. The use of vectors for protein expression, such as plasmids and viral vectors, is also a key trend. The application of these proteins in areas like diagnostics, therapeutics, and research is driving market growth. The future of protein expression lies in the development of more efficient and cost-effective methods for large-scale production.

Research report provides comprehensive data on impact of trend. For more details-
Download a Sample Report

Market
Challenges

  • The Protein Expression Market faces a significant challenge due to the shortage of technically skilled and trained laboratory professionals. With the increasing use of protein expression products, the demand for proficient staff is escalating. However, laboratories are under pressure to deliver results quickly, leading to neglected training programs for executives. Additionally, the attrition rate of laboratory professionals is rising due to factors like inadequate salaries, insufficient training, and a lack of awareness about the profession. These issues are expected to persist, potentially hindering market growth during the forecast period.
  • The Protein Expression market faces several challenges in producing high-quality proteins for various applications. One challenge is the difficulty in achieving consistent and large-scale production of complex proteins. Another issue is the high cost of producing certain proteins, particularly those that require specialized expression systems or post-production processing. Additionally, ensuring the purity and functionality of expressed proteins can be a significant challenge. Furthermore, regulatory requirements and the need for sterile production environments add complexity to the process. Lastly, the demand for novel and custom proteins continues to grow, requiring continuous innovation and investment in new technologies.

For more insights on driver and challenges
-
Request a
sample report!

Segment Overview

This protein expression market report extensively covers market segmentation by

  • Solution
    • 1.1 Products
    • 1.2 Services
  • End-user
    • 2.1 Pharmaceutical and biotechnological companies
    • 2.2 Academic research
    • 2.3 Contract research organizations
  • Geography
    • 3.1 North America
    • 3.2 Europe
    • 3.3 Asia
    • 3.4 Rest of World (ROW)


    1.1
    Products-
    The Protein Expression Market is a significant business sector, driven by the increasing demand for recombinant proteins in various industries. Biotechnology companies are the key players, utilizing bacteria, yeast, and mammalian cells to produce these proteins. The market's growth is fueled by advancements in protein engineering and technology, enabling the production of complex proteins for therapeutic, diagnostic, and research applications.

    For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) - Download a Sample Report

    Research Analysis

    The protein expression market in the life sciences sector is experiencing significant growth due to the increasing demand for advanced reagents and instruments for research and development in areas such as protein-protein interaction, gene expression, and protein engineering. Protein expression reagents play a crucial role in the production of recombinant proteins, which are essential for understanding the functions of genes and developing protein therapeutics. Instruments used in protein expression technologies enable researchers to study growth dynamics and investigate chronic diseases, including cardiovascular diseases and rheumatoid arthritis. Webinars and other educational resources provide valuable insights into the latest advancements in protein expression technologies, such as cell-free expression and genetic engineering. Biomarkers derived from protein expression studies are also gaining importance in the diagnosis and treatment of various diseases. Protein therapeutics, such as Humira, have revolutionized the treatment landscape for several chronic conditions, further fueling the demand for protein expression technologies.

    Market Research Overview

    The Protein Expression Market encompasses the production of proteins for research, therapeutic, and industrial applications. This market is driven by the increasing demand for protein-based drugs and diagnostic tools. Technologies such as Escherichia coli (E. Coli) expression, yeast expression, and mammalian cell expression are commonly used for protein production. The market is segmented based on protein type, application, and end user. Proteins expressed include recombinant proteins, monoclonal antibodies, and enzymes. Applications include research, therapeutics, and industrial uses. End users include pharmaceutical and biotechnology companies, academic and research institutions, and diagnostic laboratories. The market is expected to grow due to the rising demand for protein-based therapeutics and diagnostics.

    Table of Contents:

    1 Executive Summary
    2 Market Landscape
    3 Market Sizing
    4 Historic Market Size
    5 Five Forces Analysis
    6 Market Segmentation

    • Solution
      • Products
      • Services
    • End-user
      • Pharmaceutical And Biotechnological Companies
      • Academic Research
      • Contract Research Organizations
    • Geography
      • North America
      • Europe
      • Asia
      • Rest Of World (ROW)


    7
    Customer Landscape
    8 Geographic Landscape
    9 Drivers, Challenges, and Trends
    10 Company Landscape
    11 Company Analysis
    12 Appendix

    About Technavio

    Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

    With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

    Contacts

    Technavio Research
    Jesse Maida
    Media & Marketing Executive
    US: +1 844 364 1100
    UK: +44 203 893 3200
    Email:
    [email protected]
    Website:

    SOURCE Technavio

    MENAFN28062024003732001241ID1108386601


  • PR Newswire

    Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.